OCT 14, 2016 11:14 AM PDT

T Cell Infusion Method Enhances Anti-Cancer Effect

WRITTEN BY: Kara Marker
Enhancing a cancer patient’s own T cells to reduce tumor growth is an up-and-coming cancer therapy that is being used to treat multiple types of tumor growth. A new study from the Medical University of South Carolina, in collaboration with Loyola University, offers a new way to insure that the enhanced T cells survived once they re-enter the body.
Credit: Medical University of South Carolina
Adoptive cell therapy (ACT) began as an immune-boosting cancer treatment as scientists began infusing autologous, melanoma-specific T cells obtained from the patient’s own supply of cells. After obtaining the cells, researchers genetically modify them with therapeutic receptors, activate them, and then stimulate them to proliferating before facilitating a therapeutic re-infusion back into the patient’s bloodstream. 

Unfortunately, rapid proliferation before reinfusion makes T cells increasingly prone to activation induced cell death (AICD), and the best results only occur when the transferred enhanced T cells survive. Fast-forward to this study and the authors’ current goals: how can they prevent AICD to enhance ACT’s effectiveness at targeting cancer, mainly melanoma? After extensive experimentation, they found that culturing the T cells in N-acetyl cysteine (NAC) before re-infusion protects them from AICD, making the immunotherapy increasingly effective and outcomes much more promising in a preclinical model of melanoma.

The collaborative effort led to the researchers seeing significant improvements in T cell persistence and overall outcomes when they added NAC to the in vitro T cell expansion culture. Apparently, NAC prevents increases in a DNA damage marker called yH2AX. Specifically, 40 percent of NAC-cultured T cells were detectable in tumors post-re-infusion as compared to only 1.2 percent of standard-culture T cells. 

"We were really surprised," said senior author of the recent Cancer Research study Christina Voelkel-Johnson, PhD, from the Medical University of South Carolina. "Given the harsh environment T cells encounter within tumors, we did not expect that the number of NAC-cultured T cells would be 33-fold higher than T cells not cultured in NAC." Plus, in mice models, they saw a significant delay of tumor growth in mice receiving T cell re-infusion after being cultured in NAC.

Their studies show that NAC culture reduces the level of reactive oxygen species (ROS), which reduces the amount of damage done to the DNA through an extensive molecular pathway of kinases, tumor proteins, and antibodies. When less DNA damage occurs in T cells, the body’s regulatory cells don’t have to make a choice between repair and cell death, reducing the overall rate of T cells destroyed because of DNA damage.

Next up: how does NAC culturing of T cells affect their phenotype? How does it work? In Voelkel-Johnson’s words: “There may be benefits to culturing T cells in NAC aside from generating AICD resistance that we haven't yet recognized."

More about melanoma:

Melanoma is a cancer that begins in the melanocytes. It’s less common than basal cell and squamous cell skin cancers, but it’s more dangerous because it is more likely to metastasize if not treated early. The American Cancer Society estimates that more than ten thousand people in the United States will die from melanoma in 2016.
 


Sources: Medical University of South Carolina, American Cancer Society
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
MAR 16, 2021
Immunology
What Happens When Your Immune System Forgets
MAR 16, 2021
What Happens When Your Immune System Forgets
One of the most remarkable features of the immune system is its ability to “remember” past encounters with p ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
MAY 18, 2021
Immunology
Pizza's (Temporary) Effect on the Immune System
MAY 18, 2021
Pizza's (Temporary) Effect on the Immune System
Too much salt isn’t good for you—we know that it can contribute to elevated blood pressure, cardiovascular a ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
Loading Comments...